Compass Therapeutics Statistics
NASDAQ: CMPXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.6882+0.0097 (+1.43%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Compass Therapeutics by the numbers
Compass Therapeutics has a market capitalization of $123.9 million based on 180.09M shares outstanding. With trailing EPS of $-0.46, Compass Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 30.1% below its 50-day average and 75.3% below its 200-day average.
Average daily trading volume is 3.88M shares, or about $2.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CMPX valuation vs. peer median
| Metric | CMPX | Peer median | Difference |
|---|---|---|---|
| Market cap | $123.94M | $119.31M | +4% |
| Avg. volume | 3.88M | 1.16M | +235% |
Peer median across 8 companies: IVVD, HUMA, ENGN, ARMP, FATE, CRDL, TARA, STRO.
Valuation
- Market cap
- $123.94M
- EPS (TTM)
- $-0.46
- Shares outstanding
- 180.09M
Price and trading
- Previous close
- 0.6785
- Open
- 0.6711
- Day range
- 0.6405 – 0.7297
- 52-week range
- 0.57 – 6.88
- 52-week change
- -85.87%
- 50-day moving average
- 0.9839
- Beta
- —
- Volume
- 1.82M
- Average volume
- 3.88M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 123.94M
- Forward Pe
- -1.17
- Eps
- -0.46
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 6.88
- Week52 Low
- 0.57
- Avg Volume
- 3.88M
- Shares Outstanding
- 180.09M
- Ma50
- 0.98
- Ma200
- 2.78
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -90.00%
- Pct From52w Low
- 20.74%